praziquantel has been researched along with Seizures in 25 studies
azinox: Russian drug
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Children with persistent neurocysticercosis were randomized into 3 groups-albendazole (n = 19), albendazole and praziquantel (n = 21), and placebo (n = 20)-for 30 days and followed up at 3 and 6 months for resolution and recurrence of seizures." | 9.51 | Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial. ( Khandelwal, N; Saini, AG; Singh, K; Singhi, P, 2022) |
| "To evaluate the efficacy and safety of a combination of albendazole and praziquantel in children with seizures and single small enhancing computerized tomographic lesions." | 9.14 | Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. ( Kaur, S; Khandelwal, N; Singhi, P; Singhi, S, 2009) |
| "55%; P = 0." | 6.43 | Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. ( Coffey, CS; Del Brutto, OH; García, HH; Roos, KL, 2006) |
| "Children with persistent neurocysticercosis were randomized into 3 groups-albendazole (n = 19), albendazole and praziquantel (n = 21), and placebo (n = 20)-for 30 days and followed up at 3 and 6 months for resolution and recurrence of seizures." | 5.51 | Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial. ( Khandelwal, N; Saini, AG; Singh, K; Singhi, P, 2022) |
| "To evaluate the efficacy and safety of a combination of albendazole and praziquantel in children with seizures and single small enhancing computerized tomographic lesions." | 5.14 | Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. ( Kaur, S; Khandelwal, N; Singhi, P; Singhi, S, 2009) |
| "Plasma praziquantel concentrations were measured in 11 Thai patients with active neurocysticercosis (8 males and 3 females)." | 5.08 | Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone. ( Karbwang, J; Na-Bangchang, K; Vanijanonta, S, 1995) |
| "Anthelminthic treatment with albendazole provides improved rates of seizure freedom and hastens resolution of the granuloma." | 4.89 | Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. ( Otte, WM; Sander, JW; Singh, G; Singla, M, 2013) |
| "Cyst resolution was unsatisfactory with albendazole monotherapy but was very high when it was followed by a combination of albendazole and praziquantel." | 4.31 | Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study. ( Bottieau, E; Carabin, H; Dorny, P; Fleury, A; Gabriël, S; Jackson, E; Magnussen, P; Makasi, C; Mwape, KE; Ngowi, BJ; Prazeres da Costa, C; Prodjinotho, UF; Ruether, C; Schmidt, V; Stelzle, D; Trevisan, C; Van Damme, I; Winkler, AS; Zulu, G, 2023) |
| " Lastly, widespread neurocysticercosis may be a concern in mass treatment programs that provide praziquantel (for managing schistosomiasis) or albendazole (for managing intestinal worms or lymphatic filariasis) because these drugs may kill cerebral cysticerci, resulting in severe adverse events." | 3.74 | Could neurocysticercosis be the cause of "onchocerciasis-associated" epileptic seizures? ( Eberhard, M; Habumogisha, P; Katabarwa, M; Lakwo, T; Richards, F, 2008) |
| "Neurocysticercosis is a parasitic infection of the central nervous system by the larval stage of the pork tapeworm and is a common cause of seizures and epilepsy in endemic areas." | 2.72 | Anthelmintics for people with neurocysticercosis. ( Abba, K; Monk, EJM; Ranganathan, LN, 2021) |
| "55%; P = 0." | 2.43 | Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. ( Coffey, CS; Del Brutto, OH; García, HH; Roos, KL, 2006) |
| "Praziquantel was not used." | 2.37 | Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. ( Crawford, TO; Mitchell, WG, 1988) |
| "When she presented with further seizures 6 months later, attempts to arrange neuroimaging and specialist assessment were unsuccessful owing to restrictions on routine healthcare services during the SARS-CoV-2 nationwide lockdown." | 1.62 | Hydatid brain cyst: A delayed diagnosis in a rural setting during COVID-19. ( Brink, AJ; Da Fonseca, SP; Enslin, JMN; Nuttall, J; Opperman, CJ; Tootla, HD, 2021) |
| "Neurocysticercosis is an unusual cause of seizure in the New Zealand setting." | 1.38 | Neurocysticercosis: an unusual cause of seizure in the New Zealand setting. ( Heron, P; Pybus, M, 2012) |
| "In Japan neurocysticercosis is a rare disease." | 1.31 | [A case of neurocysticercosis presenting as focal seizure]. ( Higuchi, H; Kobayashi, N; Okada, T; Sugiyama, M; Teramoto, A; Yabe, Y, 2000) |
| "After medical treatment of neurocysticercosis, there is usually remission or marked improvement in the associated seizure disorder." | 1.28 | The course of seizures after treatment for cerebral cysticercosis. ( Sotelo, J; Vazquez, V, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Opperman, CJ | 1 |
| Enslin, JMN | 1 |
| Nuttall, J | 1 |
| Brink, AJ | 1 |
| Da Fonseca, SP | 1 |
| Tootla, HD | 1 |
| Singh, K | 1 |
| Saini, AG | 1 |
| Khandelwal, N | 2 |
| Singhi, P | 2 |
| Stelzle, D | 1 |
| Makasi, C | 1 |
| Schmidt, V | 1 |
| Trevisan, C | 1 |
| Van Damme, I | 1 |
| Ruether, C | 1 |
| Dorny, P | 1 |
| Magnussen, P | 1 |
| Zulu, G | 1 |
| Mwape, KE | 1 |
| Bottieau, E | 1 |
| Prazeres da Costa, C | 1 |
| Prodjinotho, UF | 1 |
| Carabin, H | 1 |
| Jackson, E | 1 |
| Fleury, A | 1 |
| Gabriël, S | 1 |
| Ngowi, BJ | 1 |
| Winkler, AS | 1 |
| Landzberg, DR | 1 |
| Dhir, A | 1 |
| Jillella, DV | 1 |
| Monk, EJM | 1 |
| Abba, K | 1 |
| Ranganathan, LN | 1 |
| Garcia, HH | 2 |
| Del Brutto, OH | 3 |
| Kaur, S | 1 |
| Singhi, S | 1 |
| George, J | 1 |
| Rose, D | 1 |
| Hazrati, LN | 1 |
| Majl, L | 1 |
| Hodaie, M | 1 |
| Hewagama, SS | 1 |
| Darby, JD | 1 |
| Sheorey, H | 1 |
| Daffy, JR | 1 |
| Pybus, M | 1 |
| Heron, P | 1 |
| Takayanagui, OM | 1 |
| Odashima, NS | 1 |
| Bonato, PS | 1 |
| Lima, JE | 1 |
| Lanchote, VL | 1 |
| Otte, WM | 1 |
| Singla, M | 1 |
| Sander, JW | 2 |
| Singh, G | 2 |
| Narula, G | 1 |
| Bawa, KS | 1 |
| Roos, KL | 1 |
| Coffey, CS | 1 |
| Katabarwa, M | 1 |
| Lakwo, T | 1 |
| Habumogisha, P | 1 |
| Richards, F | 1 |
| Eberhard, M | 1 |
| Hayashi, M | 1 |
| Matsuda, H | 1 |
| Tormis, LC | 1 |
| Nosenas, JS | 1 |
| Blas, BL | 1 |
| Shandera, WX | 1 |
| White, AC | 1 |
| Chen, JC | 1 |
| Diaz, P | 1 |
| Armstrong, R | 1 |
| Na-Bangchang, K | 1 |
| Vanijanonta, S | 1 |
| Karbwang, J | 1 |
| Buitrago, M | 1 |
| Edwards, B | 1 |
| Rosner, F | 1 |
| Sugiyama, M | 1 |
| Okada, T | 1 |
| Higuchi, H | 1 |
| Yabe, Y | 1 |
| Kobayashi, N | 1 |
| Teramoto, A | 1 |
| Vazquez, V | 1 |
| Sotelo, J | 1 |
| Mitchell, WG | 1 |
| Crawford, TO | 1 |
| Rosenthal, RE | 1 |
| Emsellem, HA | 1 |
| Kline, PP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characteristics of Patients With Symptomatic Active Neurocysticercosis and Effect of Treatment on Symptoms, Lesions and Quality of Life in Resource-poor Rural Areas of Eastern Africa - TOPANA, a Multi-centre Prospective Cohort Study.[NCT03834337] | 63 participants (Actual) | Observational | 2019-04-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for praziquantel and Seizures
| Article | Year |
|---|---|
Anthelmintics for people with neurocysticercosis.
Topics: Adult; Albendazole; Anticestodal Agents; Bias; Brain Diseases; Child; Humans; Neurocysticercosis; Pl | 2021 |
Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Topics: Albendazole; Anticestodal Agents; Antiparasitic Agents; Brain; Cysts; Epilepsy; Female; Humans; Infl | 2017 |
Medical management of neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Brain Diseases; Humans; Life Cycle Stages; Magnetic Resonance I | 2011 |
Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.
Topics: Adolescent; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Calcinosis; Child; Child, Preschoo | 2013 |
Neurocysticercosis--New Millennium, ancient disease and unending debate.
Topics: Albendazole; Animals; Anthelmintics; Anticonvulsants; Humans; Neurocysticercosis; Praziquantel; Seiz | 2003 |
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
Topics: Albendazole; Anthelmintics; Humans; Neurocysticercosis; Praziquantel; Radiography; Secondary Prevent | 2006 |
Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment.
Topics: Acute Disease; Adolescent; Adult; Animals; Black People; Brain Diseases; Calcinosis; Carbamazepine; | 1988 |
3 trials available for praziquantel and Seizures
| Article | Year |
|---|---|
Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
Topics: Adolescent; Albendazole; Anthelmintics; Child; Child, Preschool; Drug Therapy, Combination; Humans; | 2022 |
Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Double-Blind Method; Drug | 2009 |
Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone.
Topics: Adult; Anticonvulsants; Antiplatyhelmintic Agents; Biological Availability; Brain Diseases; Cysticer | 1995 |
15 other studies available for praziquantel and Seizures
| Article | Year |
|---|---|
Hydatid brain cyst: A delayed diagnosis in a rural setting during COVID-19.
Topics: Albendazole; Anticestodal Agents; Brain Diseases; Child; COVID-19; Delayed Diagnosis; Echinococcosis | 2021 |
Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.
Topics: Albendazole; Anthelmintics; Antiparasitic Agents; Cysts; Humans; Neurocysticercosis; Praziquantel; P | 2023 |
Radiographic Improvement of Larval Cysts in Neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Brain; Humans; Magnetic Resonance Imaging; Male; | 2021 |
Cerebral schistosomiasis--an unusual presentation of an intracranial mass lesion.
Topics: Adult; Animals; Anthelmintics; Anti-Inflammatory Agents; Anticonvulsants; Antitubercular Agents; Bra | 2009 |
Seizures related to praziquantel therapy in neurocysticercosis.
Topics: Anthelmintics; Humans; Male; Neurocysticercosis; Praziquantel; Seizures; Young Adult | 2010 |
Neurocysticercosis: an unusual cause of seizure in the New Zealand setting.
Topics: Anthelmintics; Child; Humans; Male; Neurocysticercosis; New Zealand; Praziquantel; Radiography; Seiz | 2012 |
Neurocysticercosis in Australia: still free of autochthonous cases?
Topics: Anthelmintics; Female; Frontal Lobe; Humans; Male; Neurocysticercosis; Praziquantel; Refugees; Seizu | 2012 |
Anticysticercal treatment and seizures in neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Clinical Trials as Topic; Humans; Neurocysticercosis; Praziquan | 2004 |
Could neurocysticercosis be the cause of "onchocerciasis-associated" epileptic seizures?
Topics: Albendazole; Animals; Anthelmintics; Epilepsy; Humans; Neurocysticercosis; Onchocerca; Onchocerciasi | 2008 |
Clinical study on cerebral schistosomiasis japonica on Leyte Island, Philippines: follow-up study 6 years after treatment with antischistosomal drugs.
Topics: Adult; Anticonvulsants; Benzenesulfonates; Brain Diseases; Drug Therapy, Combination; Female; Humans | 1984 |
Neurocysticercosis in Houston, Texas. A report of 112 cases.
Topics: Adolescent; Adult; Animals; Brain Diseases; Child; Cysticercosis; Female; Humans; Male; Middle Aged; | 1994 |
Neurocysticercosis: Report of fifteen cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiplatyhelmintic Agents; Brain Diseases; Child; Cystic | 1995 |
[A case of neurocysticercosis presenting as focal seizure].
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Combined Modality Therapy; Humans; Male; Neurocys | 2000 |
The course of seizures after treatment for cerebral cysticercosis.
Topics: Adult; Albendazole; Brain; Brain Diseases; Cysticercosis; Epilepsy; Female; Follow-Up Studies; Human | 1992 |
Truncal seizures: an unusual presentation of cerebral cysticercosis.
Topics: Adult; Carbamazepine; Cysticercosis; Female; Humans; Movement Disorders; Praziquantel; Prednisone; S | 1986 |